Tilray Revenue and Competitors

Nanaimo, BC CAN

Location

$48.6M

Total Funding

Cannabis

Industry

Estimated Revenue & Valuation

  • Tilray's estimated annual revenue is currently $563.6M per year.(i)
  • Tilray received $100.0M in venture funding in October 2018.
  • Tilray's estimated revenue per employee is $890,395
  • Tilray's total funding is $48.6M.
  • Tilray's current valuation is $3.3B. (January 2022)

Employee Data

  • Tilray has 633 Employees.(i)
  • Tilray grew their employee count by 2% last year.

Tilray's People

NameTitleEmail/Phone
1
VP Strategic InitiativesReveal Email/Phone
2
Head Global Government & Public AffairsReveal Email/Phone
3
Head QualityReveal Email/Phone
4
Security OfficerReveal Email/Phone
5
VP HospitalityReveal Email/Phone
6
SVP Supply Chain/OperationsReveal Email/Phone
7
SVP Commercial Operations & Strategy; Fresh Hemp FoodsReveal Email/Phone
8
VP Sales Tilray Beverage BrandsReveal Email/Phone
9
VP, Strategy & Business DevelopmentReveal Email/Phone
10
SVP FinanceReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$55.6M278428%$2.1B$8.2B
#2
$300M24803%$560.5MN/A
#3
$27.1M1948%$89.5MN/A
#4
$79.7M25910%$86.5MN/A
Add Company

What Is Tilray?

Tilray is a global leader in medical cannabis research and production dedicated to providing safe, consistent and reliable therapy to patients. We are the only GMP certified medical cannabis producer currently supplying products to thousands of patients, physicians, pharmacies, hospitals, governments and researchers in Australia, Canada, the European Union and the Americas.

keywords:N/A

$48.6M

Total Funding

633

Number of Employees

$563.6M

Revenue (est)

2%

Employee Growth %

$3.3B

Valuation

N/A

Accelerator

Tilray News

2022-04-20 - Tilray Vs. Curaleaf: Which Cannabis Stock Is a Better Buy Right Now?

With the prospect of eventual U.S. federal legalization, Tilray has also been busy expanding its footprint south of the border, a factor noted...

2022-04-17 - Tilray Stock: 3 Catalysts We're Waiting For

Tilray is the cannabis market leader in Canada, where recreational marijuana use has already been legalized. It also has brands well positioned...

2022-04-17 - Is It Too Late to Buy Tilray Stock?

The 2021 merger between two strong cannabis companies, Tilray ( TLRY -0.19% ) and Aphria, is turning out to be fruitful.

2021-08-26 - Tilray : Announces Adjournment of Special Meeting of Stockholders to September 10, 2021

Tilray Announces Adjournment of Special Meeting of Stockholders to September 10, 2021 Votes already cast point to support for both the Authorized Shares Proposal and the Governance Proposals Tilray urges stockholders to vote immediately in support of long-term value creation NEW YORK & LEAMING ...

2021-08-19 - TILRAY : ANNOUNCES ADJOURNMENT OF SPECIAL MEETING OF STOCKHOLDERS TO SEPTEMBER 10, 2021 (Form 8-K)

TILRAY ANNOUNCES ADJOURNMENT OF SPECIAL MEETING OF STOCKHOLDERS TO SEPTEMBER 10, 2021 Votes already cast point to support for both the Authorized Shares Proposal and the Governance Proposals Tilray urges stockholders to vote immediately in support of long-term value creation NEW YORK & LEAMIN ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1091.4M4331N/AN/A

Tilray Funding

DateAmountRoundLead InvestorsReference
2018-10-04$100.0MUndisclosedArticle